Skip to content
10-K

Annual Report

Oscar Health, Inc. OSCR

0001568651-26-000011

← back to feed
Filed
Feb 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 262.39M sh
Shares Diluted FY 2025 · Dec 31, 2024 265.85M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 221.66M sh
Capex FY 2025 · Dec 31, 2025 $36.37M
Capex FY 2025 · Dec 31, 2024 $27.9M
Capex FY 2025 · Dec 31, 2023 $25.58M
Operating Cash Flow FY 2025 · Dec 31, 2025 $1.09B
Operating Cash Flow FY 2025 · Dec 31, 2024 $978.19M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$272.16M
Long Term Debt FY 2025 · Dec 31, 2025 $430.1M
Long Term Debt FY 2025 · Dec 31, 2024 $299.56M
Cash And Equivalents FY 2025 · Dec 31, 2025 $2.77B
Cash And Equivalents FY 2025 · Dec 31, 2024 $1.53B
Cash And Equivalents FY 2025 · Dec 31, 2023 $1.87B
Stockholders Equity FY 2025 · Dec 31, 2025 $977.65M
Stockholders Equity FY 2025 · Dec 31, 2024 $1.01B
Current Liabilities FY 2025 · Dec 31, 2025 $4.86B
Current Liabilities FY 2025 · Dec 31, 2024 $3.46B
Total Liabilities FY 2025 · Dec 31, 2025 $5.34B
Total Liabilities FY 2025 · Dec 31, 2024 $3.82B
Current Assets FY 2025 · Dec 31, 2025 $4.61B
Current Assets FY 2025 · Dec 31, 2024 $2.85B
Total Assets FY 2025 · Dec 31, 2025 $6.33B
Total Assets FY 2025 · Dec 31, 2024 $4.84B
Eps Diluted FY 2025 · Dec 31, 2025 −$1.69
Eps Diluted FY 2025 · Dec 31, 2024 $0.10
Eps Diluted FY 2025 · Dec 31, 2023 −$1.22
Eps Basic FY 2025 · Dec 31, 2025 −$1.69
Eps Basic FY 2025 · Dec 31, 2024 $0.11
Eps Basic FY 2025 · Dec 31, 2023 −$1.22
Sga Expense FY 2025 · Dec 31, 2025 $2.05B
Sga Expense FY 2025 · Dec 31, 2024 $1.76B
Sga Expense FY 2025 · Dec 31, 2023 $1.43B
Net Income FY 2025 · Dec 31, 2025 −$443.15M
Net Income FY 2025 · Dec 31, 2024 $25.43M
Net Income FY 2025 · Dec 31, 2023 −$270.73M
Operating Income FY 2025 · Dec 31, 2025 −$396.36M
Operating Income FY 2025 · Dec 31, 2024 $57.27M
Operating Income FY 2025 · Dec 31, 2023 −$235.62M
Revenue FY 2025 · Dec 31, 2025 $28.59M
Revenue FY 2025 · Dec 31, 2024 $20.58M
Revenue restated FY 2025 · Dec 31, 2023 $21.35M